Raymond J. March | Friday June 22, 2018 at 9:00 AM PDT
Increased competition is the remedy to skyrocketing drug prices.
Increased competition is the remedy to skyrocketing drug prices.
Posturing politicians on Capitol Hill conducted a hearing a few days ago during which they grilled Heather Bresch, CEO of Mylan N.V., maker of EpiPens. Prices of EpiPens have skyrocketed in the past few years (which I have discussed here and here). The politicians were more interested in wagging their fingers and tut-tutting at...
Read More »